Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

about

Kinact: a computational approach for predicting activating missense mutations in protein kinases.

P2860

Q54978537-22569026-810B-4176-A5E7-4C8102076780

P2860

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

Item

http://www.wikidata.org/entity/Q53691581

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@en

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@nl

type

Item

label

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@en

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@nl

prefLabel

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@en

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@nl

P1476

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

@en

P2093

Janet A M Fyfe

http://www.w3.org/2001/XMLSchema#string

Malancha Karmakar

http://www.w3.org/2001/XMLSchema#string

Maria Globan

http://www.w3.org/2001/XMLSchema#string

Natasha E Holmes

http://www.w3.org/2001/XMLSchema#string

Paul D R Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosis

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.

Mechanisms of Pyrazinamide Action and Resistance

In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity.

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures

Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.

P304

541-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201712-2572LE

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Timothy Stinear

Justin T Denholm

David B Ascher

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29694240

http://www.w3.org/2001/XMLSchema#string

P932

6118032

http://www.w3.org/2001/XMLSchema#string

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

about

P2860

P2860

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932